Form 4 for RCEL AVITA Medical, Inc.
Accepted 2023-12-27 00:00:00 ET · period of report 2023-12-26 · accession 0000950170-23-073346 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-27 | 2023-12-26 | RCEL | CORBETT JAMES | CEO, Dir | S - Sale | $13.29 | -1,445 | 11.6K | -11% | -$19.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common | 2023-12-26 | S | D | 1,445 | $13.29 | 11,580 | D | — | — | (F1) Shares sold to cover tax obligation incurred by the Reporting Person upon the vesting of RSUs. (F2) Includes unvested RSUs |